• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国河南省 COVID-19 患者的临床特征和预后因素。

Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China.

机构信息

Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, Henan, China.

Department of Respiratory and Critical Care Medicine, Zhoukou Central Hospital, Zhoukou, 466000, Henan, China.

出版信息

Hum Cell. 2021 Mar;34(2):419-435. doi: 10.1007/s13577-021-00499-y. Epub 2021 Feb 13.

DOI:10.1007/s13577-021-00499-y
PMID:33586121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7882230/
Abstract

Since December 2019, the novel coronavirus SARS-CoV-2 pandemic (COVID-19) outbroke in Wuhan and spread in China. Here we aimed to investigate the clinical and radiological characteristics of COVID-19 cases. We collected and analyzed the clinical data of 172 hospitalized cases of COVID-19 who were diagnosed via qRT-PCR of nasopharyngeal swabs during January 2020 and February 2020. The chest images were reviewed by radiologists and respirologists. The older patients with COVID-19 in Henan Province had more severe disease and worse prognosis. The male sex, smoking history and Wuhan exposure of patients are not related to the severity or prognosis of COVID-19. Family gatherings were showed among 26.7% of patients. A greater proportion of patients in the severe group suffer from combined chronic diseases. CT results showed that most patients had bilateral lung lesions and multiple lung lobes. The lungs of severe patients are more damaged. Both the infection range and inflammatory factor levels are related to the poor prognosis. Antiviral drugs, immunoglobulin and traditional Chinese medicine are mainly used for the treatment of COVID-19 patients. The discharge rate of COVID-19 patients was 93.0%, and the mortality rate was 2.3%. Case type, lymphocyte ratio grade, and respiratory failure at admission are risk factors for poor prognosis, except for the number of infiltrating lung lobes. The results showed that severe disease process, lymphopenia and respiratory failure are risk factors for the COVID-19.

摘要

自 2019 年 12 月以来,新型冠状病毒 SARS-CoV-2 疫情(COVID-19)在武汉爆发并在中国蔓延。在这里,我们旨在调查 COVID-19 病例的临床和影像学特征。我们收集并分析了 2020 年 1 月至 2 月期间通过鼻咽拭子 qRT-PCR 确诊的 172 例住院 COVID-19 患者的临床数据。胸部图像由放射科医生和呼吸科医生进行评估。河南省老年 COVID-19 患者病情较重,预后较差。患者的性别、吸烟史和武汉接触史与 COVID-19 的严重程度或预后无关。26.7%的患者有家庭聚会。严重组中有更大比例的患者患有合并慢性疾病。CT 结果显示,大多数患者的肺部病变为双侧,多个肺叶受累。严重患者的肺部受损更严重。感染范围和炎症因子水平均与预后不良有关。COVID-19 患者主要使用抗病毒药物、免疫球蛋白和中药进行治疗。COVID-19 患者的出院率为 93.0%,死亡率为 2.3%。除浸润肺叶数外,病例类型、淋巴细胞比值分级和入院时呼吸衰竭是预后不良的危险因素。结果表明,严重的疾病过程、淋巴细胞减少和呼吸衰竭是 COVID-19 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc1/7882230/9522b86c61b5/13577_2021_499_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc1/7882230/10b2d681faa1/13577_2021_499_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc1/7882230/9522b86c61b5/13577_2021_499_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc1/7882230/10b2d681faa1/13577_2021_499_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdc1/7882230/9522b86c61b5/13577_2021_499_Fig2_HTML.jpg

相似文献

1
Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China.中国河南省 COVID-19 患者的临床特征和预后因素。
Hum Cell. 2021 Mar;34(2):419-435. doi: 10.1007/s13577-021-00499-y. Epub 2021 Feb 13.
2
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.中药治疗重症 COVID-19 患者的疗效和安全性评估:中国 COVID-19 疫情早期武汉的回顾性病例系列研究。
J Ethnopharmacol. 2021 Sep 15;277:113888. doi: 10.1016/j.jep.2021.113888. Epub 2021 Jan 30.
3
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.
4
Clinical Features and Outcomes of Acute Kidney Injury in Patients Infected with COVID-19 in Xiangyang, China.中国襄阳 COVID-19 感染患者的急性肾损伤的临床特征和结局。
Blood Purif. 2021;50(4-5):513-519. doi: 10.1159/000513163. Epub 2020 Dec 14.
5
Epidemiological and clinical characteristics of 671 COVID-19 patients in Henan Province, China.中国河南省 671 例 COVID-19 患者的流行病学和临床特征。
Int J Epidemiol. 2020 Aug 1;49(4):1085-1095. doi: 10.1093/ije/dyaa081.
6
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Determination of risk factors for predicting the onset of symptoms in asymptomatic COVID-19 infected patients.无症状 COVID-19 感染患者症状发作的预测风险因素的确定。
Int J Med Sci. 2020 Aug 6;17(14):2187-2193. doi: 10.7150/ijms.47576. eCollection 2020.
9
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China.107 例新型冠状病毒(SARS-CoV-2)感染患者从中国武汉两家医院出院的临床过程和转归。
Crit Care. 2020 Apr 30;24(1):188. doi: 10.1186/s13054-020-02895-6.
10
Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.比较 COVID-19 存活和死亡患者的临床、辅助检查和实验室检查结果:炎症指标在确定疾病严重程度中的诊断作用。
BMC Infect Dis. 2020 Nov 23;20(1):869. doi: 10.1186/s12879-020-05540-3.

引用本文的文献

1
Longitudinal analysis of Covid-19 infection trends and in-hospital mortality across six pandemic waves in Tunisia.突尼斯六次疫情浪潮中新冠病毒感染趋势及院内死亡率的纵向分析。
Arch Public Health. 2025 Apr 1;83(1):86. doi: 10.1186/s13690-024-01485-0.
2
The Dysregulation of the Monocyte-Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia.单核细胞与树突状细胞相互作用失调与COVID-19肺炎患者的院内死亡率相关。
J Clin Med. 2024 Apr 24;13(9):2481. doi: 10.3390/jcm13092481.
3
Clinical courses of 24,563 hospitalized COVID-19 patients during the first 12 months of the pandemic in the Central City of Iran.

本文引用的文献

1
Analysis of the Efficacy of Two Treatment Protocols for Patients with Symptomatic Oral Lichen Planus: A Randomized Clinical Trial.分析两种治疗方案对症状性口腔扁平苔藓患者的疗效:一项随机临床试验。
Int J Environ Res Public Health. 2020 Dec 23;18(1):56. doi: 10.3390/ijerph18010056.
2
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.新型冠状病毒 SARS-CoV-2 实验室诊断面临的挑战。
Viruses. 2020 May 26;12(6):582. doi: 10.3390/v12060582.
3
Hydroxychloroquine and COVID-19.羟氯喹与 COVID-19。
伊朗中心城市大流行期间 24563 名住院 COVID-19 患者的临床病程。
Sci Rep. 2023 Apr 21;13(1):6521. doi: 10.1038/s41598-023-32292-2.
4
The efficacy of traditional Chinese medicine in the treatment of the COVID-19 pandemic in Henan Province: a retrospective study.河南省中医药治疗 COVID-19 大流行的疗效:一项回顾性研究。
Eur J Med Res. 2023 Feb 13;28(1):78. doi: 10.1186/s40001-023-01006-9.
5
Determining the Health Problems Experienced by Young Adults in Turkey, Who Received the COVID-19 Vaccine.确定在土耳其接种了新冠疫苗的年轻人所经历的健康问题。
Vaccines (Basel). 2022 Sep 14;10(9):1526. doi: 10.3390/vaccines10091526.
6
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
7
COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis.COVID-19 严重程度和慢性肝病患者死亡率:系统评价和荟萃分析。
Prev Chronic Dis. 2022 Aug 25;19:E53. doi: 10.5888/pcd19.210228.
8
Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.2019冠状病毒病大流行期间传统、补充和整合医学的使用:系统评价与荟萃分析
Front Med (Lausanne). 2022 May 9;9:884573. doi: 10.3389/fmed.2022.884573. eCollection 2022.
9
Comparative Study of Early Impacts of Post-COVID-19 Pneumonia on Clinical Manifestations, Pulmonary Function, and Chest Radiographs.新型冠状病毒肺炎后肺炎的临床表现、肺功能和胸部 X 线早期影响的对比研究。
Medicina (Kaunas). 2022 Feb 1;58(2):216. doi: 10.3390/medicina58020216.
10
A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.关于树突状细胞在SARS-CoV-2感染中的作用的鸟瞰:基于免疫的疫苗的前景。
Allergy. 2022 Jan;77(1):100-110. doi: 10.1111/all.15004. Epub 2021 Jul 24.
Postgrad Med J. 2020 Sep;96(1139):550-555. doi: 10.1136/postgradmedj-2020-137785. Epub 2020 Apr 15.
4
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病(COVID-19):综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
5
Cardiovascular disease and COVID-19.心血管疾病与新型冠状病毒肺炎
Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25.
6
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
7
Covid-19 and the digestive system.Covid-19 与消化系统。
J Gastroenterol Hepatol. 2020 May;35(5):744-748. doi: 10.1111/jgh.15047. Epub 2020 Apr 19.
8
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.新型冠状病毒肺炎(COVID-19)的潜伏期来自公开报告的确诊病例:估计和应用。
Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.